All 51 FTXH (FIRST TRUST NASDAQ PHARMACEUTICALS ETF) Holdings
There are 51 FTXH holdings. Top 10 companies weight: 52.12%.
Total Market Cap: $3.72T
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (51 stocks) | +14.58% | 28.51 | 20.97 | 0.34 | +10.49% | +18.95% | 0.55 | ||||||||||
1 | LLY | Eli Lilly And Co | 7.55% | $1,146.37 | $1.03T | Drug Manufacturers - General | Healthcare | +29.14% | 48.44 | 33.67 | 0.19 | N/A | N/A | 71 | +10.82% | $1.27K | +38.32% | 0.65 |
2 | ABBV | Abbvie Inc | 7.22% | $253.44 | $432B | Drug Manufacturers - General | Healthcare | -19.65% | 139.08 | 18.02 | 0.40 | N/A | N/A | 74 | +5.18% | $267 | +21.10% | 0.28 |
3 | MRK | Merck & Co Inc | 6.85% | $124.40 | $292B | Drug Manufacturers - General | Healthcare | +5.37% | 26.93 | 47.17 | 6.13 | N/A | N/A | 68 | +7.75% | $134 | +13.73% | 0.29 |
4 | JNJ | Johnson & Johnson | 6.83% | $248.94 | $595B | Drug Manufacturers - General | Healthcare | +11.59% | 22.09 | 21.74 | 4.95 | N/A | N/A | 70 | +8.44% | $270 | +11.07% | N/A |
5 | BMY | Bristol-myers Squibb Co | 6.46% | $60.18 | $120B | Drug Manufacturers - General | Healthcare | +5.08% | 13.82 | 9.59 | 1.54 | N/A | N/A | N/A | N/A | N/A | +1.92% | N/A |
6 | VTRS | Viatris Inc | 3.84% | $16.99 | $19B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | N/A | 7.02 | 0.14 | N/A | N/A | 60 | +4.83% | $18 | +8.31% | 0.79 |
7 | BIIB | Biogen Inc | 3.53% | $199.95 | $29B | Drug Manufacturers - General | Healthcare | -15.32% | 17.41 | 14.75 | 0.64 | N/A | N/A | 65 | +13.17% | $226 | -9.14% | 0.51 |
8 | CAH | Cardinal Health Inc | 3.37% | $225.83 | $53B | Medical Distribution | Healthcare | +10.18% | 29.55 | 19.23 | 0.37 | N/A | N/A | 73 | +10.53% | $250 | +33.87% | 0.27 |
9 | VRTX | Vertex Pharmaceuticals Inc | 3.30% | $480.50 | $121B | Biotechnology | Healthcare | +9.89% | 27.99 | 25.45 | 1.72 | N/A | N/A | 72 | +15.39% | $554 | +19.61% | 0.49 |
10 | AMGN | Amgen Inc | 3.17% | $364.17 | $193B | Drug Manufacturers - General | Healthcare | +3.49% | 24.75 | 16.47 | 0.79 | N/A | N/A | 60 | -2.07% | $357 | +11.73% | 0.46 |
11 | PFE | Pfizer Inc | 3.08% | $24.75 | $141B | Drug Manufacturers - General | Healthcare | -6.35% | 11.65 | 8.58 | 0.09 | N/A | N/A | 58 | +16.32% | $29 | -4.84% | 0.38 |
12 | GILD | Gilead Sciences Inc | 3.04% | $133.21 | $164B | Drug Manufacturers - General | Healthcare | +98.59% | 17.75 | 15.22 | 0.32 | N/A | N/A | 74 | +18.83% | $158 | +18.49% | 0.35 |
13 | REGN | Regeneron Pharmaceuticals Inc | 2.92% | $672.15 | $69B | Biotechnology | Healthcare | +20.31% | 15.86 | 15.08 | 88.04 | N/A | N/A | 72 | +21.87% | $819 | +3.03% | 0.60 |
14 | UTHR | United Therapeutics Corp | 2.69% | $529.34 | $22B | Drug Manufacturers - Specialty & Generic | Healthcare | +26.56% | 17.96 | 19.49 | 1.91 | N/A | N/A | 75 | +25.34% | $663 | +23.70% | 0.41 |
15 | JAZZ | Jazz Pharmaceuticals Plc | 2.49% | $243.47 | $15B | Biotechnology | Healthcare | N/A | N/A | 13.51 | 0.96 | N/A | N/A | 78 | +7.51% | $262 | +6.61% | 0.72 |
16 | INCY | Incyte Corp | 2.45% | $115.65 | $23B | Biotechnology | Healthcare | +27.16% | 15.82 | 15.06 | N/A | N/A | N/A | 61 | -1.58% | $114 | +7.88% | 0.57 |
17 | ILMN | Illumina Inc | 2.13% | $184.68 | $29B | Diagnostics & Research | Healthcare | -6.80% | 44.12 | 35.59 | 3.34 | N/A | N/A | 60 | -9.23% | $168 | -16.96% | 1.00 |
18 | ZTS | Zoetis Inc Class A | 1.95% | $76.20 | $31B | Drug Manufacturers - Specialty & Generic | Healthcare | +10.56% | 12.08 | 11.20 | 1.05 | N/A | N/A | 67 | +50.60% | $115 | -16.45% | 0.56 |
19 | EXEL | Exelixis Inc | 1.77% | $55.53 | $14B | Biotechnology | Healthcare | +72.24% | 17.54 | 17.70 | 0.45 | N/A | N/A | 59 | -8.28% | $51 | +26.67% | 0.52 |
20 | CRL | Charles River Laboratories International Inc | 1.51% | $219.57 | $11B | Diagnostics & Research | Healthcare | N/A | N/A | 20.16 | N/A | N/A | N/A | 75 | +5.17% | $231 | -10.66% | 1.38 |
21 | MEDP | Medpace Holdings Inc | 1.42% | $527.93 | $15B | Diagnostics & Research | Healthcare | +29.42% | 32.55 | 31.95 | 1.67 | N/A | N/A | 57 | -10.53% | $472 | +23.67% | 1.00 |
22 | NBIX | Neurocrine Biosciences Inc | 1.41% | $173 | $17B | Drug Manufacturers - Specialty & Generic | Healthcare | +9.25% | 25.72 | 24.10 | 0.21 | N/A | N/A | 75 | +15.75% | $200 | +12.11% | 0.79 |
23 | ALKS | Alkermes Plc | 1.35% | $51.72 | $8.65B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | 56.04 | 136.99 | 1.96 | N/A | N/A | N/A | N/A | N/A | +16.50% | N/A |
24 | PTCT | Ptc Therapeutics Inc | 1.34% | $78.01 | $6.53B | Biotechnology | Healthcare | -16.59% | N/A | 56.82 | 0.81 | N/A | N/A | 75 | +22.97% | $96 | +12.92% | 0.99 |
25 | HALO | Halozyme Therapeutics Inc | 1.18% | $77.09 | $8.99B | Biotechnology | Healthcare | +20.06% | 25.62 | 10.78 | N/A | N/A | N/A | 67 | +8.83% | $84 | +12.87% | 0.62 |
26 | BMRN | Biomarin Pharmaceutical Inc | 1.16% | $59.11 | $11B | Biotechnology | Healthcare | -20.33% | 42.21 | 11.96 | 0.73 | N/A | N/A | 75 | +48.81% | $88 | -5.79% | 0.65 |
27 | SYRE | Spyre Therapeutics Inc | 1.12% | $97.33 | $8.05B | Biotechnology | Healthcare | -2.15% | N/A | N/A | N/A | N/A | N/A | 75 | +6.78% | $104 | -10.71% | 1.74 |
28 | TXG | 10x Genomics Inc Ordinary Shares Class A | 0.94% | $43.22 | $5.87B | Health Information Services | Healthcare | N/A | N/A | 714.29 | N/A | N/A | N/A | 60 | -7.80% | $40 | -25.16% | 2.04 |
29 | TWST | Twist Bioscience Corp | 0.93% | $87.45 | $5.76B | Diagnostics & Research | Healthcare | -10.29% | N/A | N/A | N/A | N/A | N/A | 77 | +1.20% | $89 | -6.60% | 2.02 |
30 | TVTX | Travere Therapeutics Inc Ordinary Shares | 0.90% | $55.47 | $5.24B | Biotechnology | Healthcare | -44.12% | N/A | 77.52 | N/A | N/A | N/A | 76 | +5.21% | $58 | +32.19% | 1.28 |
31 | TGTX | Tg Therapeutics Inc | 0.89% | $53.96 | $8.64B | Biotechnology | Healthcare | N/A | 18.97 | 58.48 | 0.02 | N/A | N/A | 66 | +8.19% | $58 | +7.20% | 0.80 |
32 | ELAN | Elanco Animal Health Inc | 0.87% | $25.13 | $13B | Drug Manufacturers - Specialty & Generic | Healthcare | -17.32% | N/A | 23.47 | 4.04 | N/A | N/A | 80 | +18.82% | $30 | -6.77% | 1.35 |
33 | GH | Guardant Health Inc | 0.82% | $148.07 | $21B | Diagnostics & Research | Healthcare | +1.05% | N/A | N/A | N/A | N/A | N/A | 77 | +15.54% | $171 | +4.43% | 1.17 |
34 | LGND | Ligand Pharmaceuticals Inc | 0.71% | $293.99 | $5.93B | Biotechnology | Healthcare | +26.59% | 37.91 | 34.01 | 1.53 | N/A | N/A | 80 | +5.89% | $311 | +18.82% | 0.96 |
35 | AMRX | Amneal Pharmaceuticals Inc Ordinary Shares Class A | 0.69% | $17.50 | $5.44B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | 54.57 | 6.30 | N/A | N/A | N/A | 87 | +4.29% | $18 | +29.69% | 0.89 |
36 | PTGX | Protagonist Therapeutics Inc | 0.69% | $134.27 | $8.70B | Biotechnology | Healthcare | +1.43% | N/A | 29.85 | N/A | N/A | N/A | 78 | -6.79% | $125 | +22.86% | 0.21 |
37 | RCUS | Arcus Biosciences Inc | 0.65% | $28.17 | $3.52B | Biotechnology | Healthcare | +14.36% | N/A | N/A | N/A | N/A | N/A | 68 | +26.91% | $36 | -2.35% | 1.50 |
38 | CPRX | Catalyst Pharmaceuticals Inc | 0.64% | $31.49 | $3.85B | Biotechnology | Healthcare | +20.98% | 17.44 | 12.95 | 1.73 | N/A | N/A | 54 | +0.57% | $32 | +40.70% | 0.87 |
39 | MIRM | Mirum Pharmaceuticals Inc | 0.62% | $116.62 | $7.37B | Biotechnology | Healthcare | -34.51% | N/A | 2000.00 | N/A | N/A | N/A | 82 | +25.62% | $147 | +48.33% | 0.84 |
40 | KRYS | Krystal Biotech Inc | 0.60% | $339.22 | $10B | Biotechnology | Healthcare | N/A | 45.34 | 46.95 | 0.57 | N/A | N/A | 72 | +6.62% | $362 | +39.91% | 0.92 |
41 | MRNA | Moderna Inc | 0.60% | $59.49 | $27B | Biotechnology | Healthcare | N/A | N/A | 23.04 | N/A | N/A | N/A | 46 | -18.88% | $48 | -28.62% | 1.37 |
42 | KYMR | Kymera Therapeutics Inc Ordinary Shares | 0.59% | $111.06 | $9.38B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 79 | +12.68% | $125 | +14.19% | 1.52 |
43 | ARWR | Arrowhead Pharmaceuticals Inc | 0.58% | $71.65 | $10B | Biotechnology | Healthcare | +15.23% | N/A | 111.11 | N/A | N/A | N/A | 78 | +33.98% | $96 | +1.03% | 1.63 |
44 | ROIV | Roivant Sciences Ltd Ordinary Shares | 0.57% | $34.05 | $25B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 76 | +15.48% | $39 | 0.00% | 0.90 |
45 | ACAD | Acadia Pharmaceuticals Inc | 0.50% | $25.09 | $4.43B | Biotechnology | Healthcare | N/A | 11.73 | 76.34 | 0.19 | N/A | N/A | 72 | +30.13% | $33 | +1.12% | 0.90 |
46 | ARQT | Arcutis Biotherapeutics Inc Ordinary Shares | 0.49% | $27.53 | $3.47B | Biotechnology | Healthcare | -58.89% | N/A | 158.73 | N/A | N/A | N/A | 78 | +25.75% | $35 | +0.98% | 1.24 |
47 | SUPN | Supernus Pharmaceuticals Inc | 0.41% | $47.42 | $2.77B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | N/A | 20.16 | 1.47 | N/A | N/A | 75 | +33.91% | $64 | +11.35% | 0.49 |
48 | ALNY | Alnylam Pharmaceuticals Inc | 0.40% | $272.67 | $37B | Biotechnology | Healthcare | N/A | 117.96 | 30.49 | 0.52 | N/A | N/A | 74 | +59.47% | $435 | +8.65% | 0.81 |
49 | TARS | Tarsus Pharmaceuticals Inc Ordinary Shares | 0.36% | $56.25 | $2.47B | Biotechnology | Healthcare | N/A | N/A | 106.38 | N/A | N/A | N/A | 77 | +68.11% | $95 | +16.34% | 0.61 |
50 | IONS | Ionis Pharmaceuticals Inc | 0.32% | $52.95 | $9.08B | Biotechnology | Healthcare | -21.44% | N/A | 90.91 | N/A | N/A | N/A | 79 | +75.54% | $93 | +7.60% | 0.65 |
FTXH (FIRST TRUST NASDAQ PHARMACEUTICALS ETF) Sector Allocation
HEALTHCARE
98.70%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%MATERIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%